Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm Shift

Source : https://ascopubs.org/doi/full/10.1200/OP.21.00032

Multiple myeloma (MM) is a genetically heterogenous disease and remains mostly incurable with a small group of patients achieving long-term disease remission. The past decade witnessed enormous efforts to break the circulus vitiosus of tumor-induced immunosuppression and to re-engage the immune system to fight cancer.